| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | May 12, 2025 | OCULAR THERAPEUTIX, INC | Director | Buy | 90.0 | +10,000 | 6.15% | ✗ | $69.6K |
| Sep 30, 2022 | Oct 3, 2022 | HARROW, INC. | Director | Sell | 12.5 | -40,000 | -24.08% | ✓ | $504.8K |
| Sep 24, 2021 | Sep 27, 2021 | HARROW, INC. | Director | Sell | 45.0 | -3,900 | -2.29% | ✓ | $39.2K |
| Sep 15, 2021 | Sep 17, 2021 | HARROW, INC. | Director | Sell | 25.0 | -20,000 | -10.53% | ✓ | $181.4K |
| May 20, 2021 | May 21, 2021 | OCULAR THERAPEUTIX, INC | Director | Sell | 22.5 | -10,000 | -10.00% | ✗ | $143K |
| May 20, 2021 | May 21, 2021 | HARROW, INC. | Director | Sell | 22.5 | -10,000 | -5.00% | ✗ | $107.5K |
| Mar 13, 2019 | Mar 14, 2019 | OCULAR THERAPEUTIX, INC | Director | Buy | 95.0 | +56,441 | 129.57% | ✗ | $244.4K |
| Dec 19, 2016 | Dec 21, 2016 | HARROW, INC. | Director | Buy | 95.0 | +100,000 | 100.00% | ✗ | $179K |